论文部分内容阅读
广州中恒集团创业发展多年,南粤这片热土见证和哺育着企业的创立和不断发展壮大,成为实力雄厚的行业领头羊,并在广东肇庆高新区投资建设了一家以原料药及制剂生产、保健食品生产为主导,集药品、食品保健品生产、研发及医药综合物流于一体的中恒(大旺)国际生物医药物流产业园。中恒(大旺)国际生物医药物流产业园项目总占地面积6000亩,计划总投资131.9亿元,预计年总产值约700亿元,年总创税30亿元以上。其中,医药、保健食品生产基地项目投资约
Guangzhou Zhongheng Group Venture Development for many years, this piece of land in southern Guangdong witness and nurture the establishment and development of enterprises continue to grow and become a strong leader in the industry, and Zhaoqing Hi-tech Zone in Guangdong invested in building an API and preparation production, health care Food production-led, in medicine, food and health products production, research and development and pharmaceutical integrated logistics in one of the constant (Wang) International Biomedical Logistics Industrial Park. The total area of 6,000 hectares in Zhongheng (Dawang) International Biopharmaceutical Logistics Industrial Park is planned to be 13.99 billion yuan. The estimated annual gross output value is about 70 billion yuan and the total annual tax record is 3 billion yuan. Among them, medicine, health food production base project investment about